These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9559326)
1. Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure. Yatsu T; Arai Y; Sudoh K; Shibasaki M; Uchida W; Inagaki O; Tanaka A; Takenaka T Gen Pharmacol; 1998 May; 30(5):733-7. PubMed ID: 9559326 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs. Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677 [TBL] [Abstract][Full Text] [Related]
3. Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure. Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Takenaka T Gen Pharmacol; 1998 Nov; 31(5):803-7. PubMed ID: 9809482 [TBL] [Abstract][Full Text] [Related]
4. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs. Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs. Yatsu T; Miyamoto I; Kaneko-Takanuki F; Watanabe T; Takenaka T J Pharm Pharmacol; 1997 Sep; 49(9):892-6. PubMed ID: 9306257 [TBL] [Abstract][Full Text] [Related]
6. Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature. Yatsu T; Uchida W; Inagaki O; Tanaka A; Takenaka T Gen Pharmacol; 1997 Aug; 29(2):229-32. PubMed ID: 9251904 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435. Takenaka T; Forster H; Epstein M J Pharmacol Exp Ther; 1993 Mar; 264(3):1154-9. PubMed ID: 8095547 [TBL] [Abstract][Full Text] [Related]
8. The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure. Kamijo T; Tomaru T; Miwa AY; Nakamura F; Kido H; Sugimoto T; Uchida Y Jpn J Pharmacol; 1994 Jul; 65(3):223-31. PubMed ID: 7799523 [TBL] [Abstract][Full Text] [Related]
9. Effects of YM435, a novel dopamine D1 receptor agonist, on pancreatic exocrine secretion in anesthetized dogs. Iwatsuki K; Ren LM; Chiba S Eur J Pharmacol; 1992 Aug; 218(2-3):237-41. PubMed ID: 1425944 [TBL] [Abstract][Full Text] [Related]
10. [Effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) on congestive heart failure in dogs]. Sonoki H; Uchida Y; Masuo M; Tomaru T; Katoh A; Sugimoto T Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):47-53. PubMed ID: 2952569 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721 [TBL] [Abstract][Full Text] [Related]
12. [Effects of intravenous infusion of isosorbide dinitrate (ISDN) on acute experimental congestive heart failure]. Ohhara H; Takeda M; Igarashi T Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):343-50. PubMed ID: 6671626 [TBL] [Abstract][Full Text] [Related]
13. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure]. Xu XW; Zeng GY; Yang Y; Liu HX Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856 [TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats. Nekooeian AA; Tabrizchi R Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, resolution, and renal vasodilation activity of novel DA1 agonists: 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. Anan H; Tanaka A; Tsuzuki R; Yokota M; Yatsu T; Honda K; Asano M; Fujita S; Furuya T; Fujikura T Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2910-4. PubMed ID: 1839245 [TBL] [Abstract][Full Text] [Related]
16. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat. Nekooeian AA; Tabrizchi R Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574 [TBL] [Abstract][Full Text] [Related]
17. 4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship. Anan H; Tanaka A; Tsuzuki R; Yokota M; Yatsu T; Fujikura T Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1865-70. PubMed ID: 8904813 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure. Nagata K; Iwase M; Sobue T; Yokota M J Am Coll Cardiol; 1995 Feb; 25(2):295-304. PubMed ID: 7829780 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure. Sweet CS; Ludden CT; Frederick CM; Ribeiro LG Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558 [TBL] [Abstract][Full Text] [Related]
20. Evidence against a role for dopamine D1 receptors in the myocardium of the pig. Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]